Brendan M. Johnson

An in vitro examination of the impact of polyethylene glycol 400, pluronic P85, and vitamin E d-a-tocopheryl polyethylene glycol 1000 succinate on P-glycoprotein efflux and enterocyte-based metabolism in excised rat intestine

Brendan M. Johnson, William N. Charman, Christopher J. H. Porter · AAPS PharmSci · 2002 · 192 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +16

Four-Week Studies of Oral Hypoxia-Inducible Factor–Prolyl Hydroxylase Inhibitor GSK1278863 for Treatment of Anemia

Louis Holdstock, Amy M. Meadowcroft, Rayma Maier et al. · Journal of the American Society of Nephrology · 2015 · 189 citations

Medicine, Pharmacology, Pharmacotherapy +16

A Novel Hypoxia-Inducible Factor−Prolyl Hydroxylase Inhibitor (GSK1278863) for Anemia in CKD: A 28-Day, Phase 2A Randomized Trial

Richard A. Brigandi, Brendan M. Johnson, Coreen Oei et al. · American Journal of Kidney Diseases · 2016 · 159 citations · Full text

Medicine, Hematology, Pharmacology +17

CHARACTERIZATION OF TRANSPORT PROTEIN EXPRESSION IN MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN (MRP) 2-DEFICIENT RATS

Brendan M. Johnson, Peijin Zhang, John D. Schuetz et al. · Drug Metabolism and Disposition · 2005 · 114 citations

Pharmacy, Biochemistry, Pharmacology +16

Daprodustat for anemia: a 24-week, open-label, randomized controlled trial in participants on hemodialysis

Amy M. Meadowcroft, Borut Čižman, Louis Holdstock et al. · Clinical Kidney Journal · 2018 · 105 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15